Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1994 1
1995 1
1996 2
1997 2
1998 7
1999 5
2000 4
2001 5
2002 3
2003 7
2004 1
2005 8
2006 4
2007 5
2008 8
2009 4
2010 2
2011 1
2012 4
2013 2
2014 1
2016 1
2020 1
2021 3
2022 2
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Diabetes mellitus and hyperhomocysteinemia.
van Guldener C, Stehouwer CD. van Guldener C, et al. Semin Vasc Med. 2002 Feb;2(1):87-95. doi: 10.1055/s-2002-23099. Semin Vasc Med. 2002. PMID: 16222599 Review.
Homocysteine and renal disease.
van Guldener C, Robinson K. van Guldener C, et al. Semin Thromb Hemost. 2000;26(3):313-24. doi: 10.1055/s-2000-8407. Semin Thromb Hemost. 2000. PMID: 11011849 Review.
Homocysteine-lowering treatment: an overview.
van Guldener C, Stehouwer CD. van Guldener C, et al. Expert Opin Pharmacother. 2001 Sep;2(9):1449-60. doi: 10.1517/14656566.2.9.1449. Expert Opin Pharmacother. 2001. PMID: 11585023 Review.
Homocysteine metabolism in renal disease.
van Guldener C, Stehouwer CD. van Guldener C, et al. Clin Chem Lab Med. 2003 Nov;41(11):1412-7. doi: 10.1515/CCLM.2003.217. Clin Chem Lab Med. 2003. PMID: 14656019 Review.
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
Haas S, Camm JA, Harald D, Steffel J, Virdone S, Pieper K, Brodmann M, Schellong S, Misselwitz F, Kayani G, Kakkar AK; GARFIELD-AF Investigators. Haas S, et al. Clin Res Cardiol. 2023 Jun;112(6):759-771. doi: 10.1007/s00392-022-02079-y. Epub 2022 Sep 12. Clin Res Cardiol. 2023. PMID: 36094573
Does homocysteine cause hypertension?
Stehouwer CD, van Guldener C. Stehouwer CD, et al. Among authors: van guldener c. Clin Chem Lab Med. 2003 Nov;41(11):1408-11. doi: 10.1515/CCLM.2003.216. Clin Chem Lab Med. 2003. PMID: 14656018 Review.
Homocysteine and blood pressure.
van Guldener C, Nanayakkara PW, Stehouwer CD. van Guldener C, et al. Curr Hypertens Rep. 2003 Feb;5(1):26-31. doi: 10.1007/s11906-003-0007-z. Curr Hypertens Rep. 2003. PMID: 12530932 Review.
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial.
Burggraaf-van Delft JLI, van Rein N, Bemelmans RHH, van den Berg JK, Bruggeman CY, Cloos-van Balen M, Coppens M, Eefting M, Ende-Verhaar Y, van Es N, van Guldener C, de Jong WK, Kleijwegt F, Koster T, Kroon C, Kuipers S, Leentjens J, Luijten D, Mairuhu ATA, Meijer K, van de Ree MA, Roos R, Schrover I, Swart-Heikens J, van der Velden AWG, van den Akker-van Marle EM, le Cessie S, Geersing GJ, Middeldorp S, Huisman MV, Klok FA, Cannegieter SC; L-TRRiP investigators. Burggraaf-van Delft JLI, et al. Among authors: van guldener c. BMJ Open. 2024 Mar 23;14(3):e078676. doi: 10.1136/bmjopen-2023-078676. BMJ Open. 2024. PMID: 38521524 Free PMC article.
81 results